Select Medical's Existing Debt to Remain Outstanding Post-Merger Completion
SEM sits 38% above its 52-week low of $11.65.
Summary
Select Medical Holdings Corporation expects its existing debt to remain outstanding following the completion of its recently announced take-private merger. This detail clarifies the financing structure of the transaction, indicating that the acquiring consortium will assume the existing debt rather than refinancing or paying it off. This information is material for debt holders and provides insight into the post-merger balance sheet and financial leverage of the private entity. This news follows the announcement just minutes prior that Select Medical will be acquired by a consortium led by its Executive Chairman, a deal that has been developing since mid-February as detailed in recent SEC filings. Investors will monitor further details regarding the merger agreement, including any changes to debt covenants or terms, and the timeline for closing the transaction.
At the time of this announcement, SEM was trading at $16.08 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $11.65 to $18.61. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.